Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 2,434 shares, a growth of 85.9% from the October 15th total of 1,309 shares. Based on an average daily volume of 2,055 shares, the days-to-cover ratio is currently 1.2 days.
Alvotech Trading Up 42.5%
NASDAQ:ALVOW traded up $0.06 during trading hours on Friday, reaching $0.20. The company had a trading volume of 2,210 shares, compared to its average volume of 4,526. Alvotech has a twelve month low of $0.12 and a twelve month high of $1.05. The business’s 50-day simple moving average is $0.32 and its two-hundred day simple moving average is $0.28.
Alvotech Company Profile
Alvotech is a biotechnology company focused on developing and manufacturing biosimilars—biologic medicines designed to be highly similar to already approved biologic drugs. Its pipeline includes treatments for autoimmune and inflammatory conditions, eye diseases and cancer. Founded in 2013 and headquartered in Reykjavík, Iceland, Alvotech operates research, development and manufacturing facilities in Iceland. The company typically commercializes its products through partners in markets around the world.
See Also
- Five stocks we like better than Alvotech
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
